Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Rbm17 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RBM17 mRNA] | CTD | PMID:31150632 | Rbm17 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Rbm17 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RBM17 mRNA | CTD | PMID:22206623 | Rbm17 | Rat | 1-chloro-2,4-dinitrobenzene | decreases expression | ISO | RBM17 (Homo sapiens) | 6480464 | Dinitrochlorobenzene results in decreased expression of RBM17 mRNA | CTD | PMID:17374397 | Rbm17 | Rat | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of RBM17 mRNA | CTD | PMID:26865667 | Rbm17 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RBM17 mRNA | CTD | PMID:22298810 | Rbm17 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RBM17 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Rbm17 | Rat | 4,4'-diaminodiphenylmethane | increases expression | ISO | Rbm17 (Mus musculus) | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of RBM17 mRNA | CTD | PMID:18648102 | Rbm17 | Rat | 4-(ethoxymethylene)-2-phenyloxazol-5-one | decreases expression | ISO | RBM17 (Homo sapiens) | 6480464 | Oxazolone results in decreased expression of RBM17 mRNA | CTD | PMID:17374397 | Rbm17 | Rat | antirheumatic drug | increases expression | ISO | RBM17 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of RBM17 mRNA | CTD | PMID:24449571 | Rbm17 | Rat | aristolochic acid A | decreases expression | ISO | RBM17 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of RBM17 mRNA | CTD | PMID:33212167 | Rbm17 | Rat | Aroclor 1254 | decreases expression | ISO | Rbm17 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of RBM17 mRNA | CTD | PMID:23650126 | Rbm17 | Rat | arsenous acid | increases expression | ISO | RBM17 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of RBM17 mRNA | CTD | PMID:20458559 | Rbm17 | Rat | benzo[a]pyrene | decreases expression | ISO | RBM17 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of RBM17 mRNA | CTD | PMID:26238291 | Rbm17 | Rat | benzo[a]pyrene | increases methylation | ISO | RBM17 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of RBM17 promoter | CTD | PMID:27901495 | Rbm17 | Rat | benzo[a]pyrene | decreases methylation | ISO | RBM17 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of RBM17 3' UTR | CTD | PMID:27901495 | Rbm17 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RBM17 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RBM17 mRNA | CTD | PMID:26238291 | Rbm17 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RBM17 mRNA | CTD | PMID:25181051|PMID:30816183|PMID:34947998 | Rbm17 | Rat | bisphenol A | decreases expression | ISO | Rbm17 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of RBM17 mRNA | CTD | PMID:33221593 | Rbm17 | Rat | bisphenol A | multiple interactions | ISO | RBM17 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Rbm17 | Rat | Bisphenol A diglycidyl ether | affects splicing | ISO | Rbm17 (Mus musculus) | 6480464 | bisphenol A diglycidyl ether affects the splicing of RBM17 mRNA | CTD | PMID:36464114 | Rbm17 | Rat | bisphenol AF | affects splicing | ISO | Rbm17 (Mus musculus) | 6480464 | bisphenol AF affects the splicing of RBM17 mRNA | CTD | PMID:36464114 | Rbm17 | Rat | Brodifacoum | decreases expression | EXP | | 6480464 | bromfenacoum results in decreased expression of RBM17 protein | CTD | PMID:28903499 | Rbm17 | Rat | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of RBM17 mRNA | CTD | PMID:33453195 | Rbm17 | Rat | caffeine | affects phosphorylation | ISO | RBM17 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of RBM17 protein | CTD | PMID:35688186 | Rbm17 | Rat | cannabidiol | decreases expression | ISO | RBM17 (Homo sapiens) | 6480464 | Cannabidiol results in decreased expression of RBM17 protein | CTD | PMID:34122009 | Rbm17 | Rat | carboplatin | decreases response to substance | ISO | RBM17 (Homo sapiens) | 6480464 | RBM17 protein results in decreased susceptibility to Carboplatin | CTD | PMID:16061639 | Rbm17 | Rat | chlorpyrifos | decreases expression | ISO | Rbm17 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of RBM17 mRNA | CTD | PMID:37019170 | Rbm17 | Rat | cisplatin | decreases expression | ISO | RBM17 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of RBM17 protein | CTD | PMID:20540955 | Rbm17 | Rat | coumarin | decreases phosphorylation | ISO | RBM17 (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of RBM17 protein | CTD | PMID:35688186 | Rbm17 | Rat | deoxynivalenol | increases phosphorylation | ISO | Rbm17 (Mus musculus) | 6480464 | deoxynivalenol results in increased phosphorylation of RBM17 protein | CTD | PMID:23352502 | Rbm17 | Rat | deoxynivalenol | increases expression | ISO | RBM17 (Homo sapiens) | 6480464 | deoxynivalenol results in increased expression of RBM17 protein | CTD | PMID:39638853 | Rbm17 | Rat | dexamethasone | multiple interactions | ISO | RBM17 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Rbm17 | Rat | diarsenic trioxide | increases expression | ISO | RBM17 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of RBM17 mRNA | CTD | PMID:20458559 | Rbm17 | Rat | Dibutyl phosphate | affects expression | ISO | RBM17 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of RBM17 mRNA | CTD | PMID:37042841 | Rbm17 | Rat | doxorubicin | decreases response to substance | ISO | RBM17 (Homo sapiens) | 6480464 | RBM17 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:16061639 | Rbm17 | Rat | doxorubicin | decreases expression | ISO | RBM17 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of RBM17 mRNA | CTD | PMID:29803840 | Rbm17 | Rat | enzyme inhibitor | multiple interactions | ISO | RBM17 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation more ... | CTD | PMID:23301498 | Rbm17 | Rat | etoposide | decreases response to substance | ISO | RBM17 (Homo sapiens) | 6480464 | RBM17 protein results in decreased susceptibility to Etoposide | CTD | PMID:16061639 | Rbm17 | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of RBM17 mRNA | CTD | PMID:30307764 | Rbm17 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of RBM17 mRNA | CTD | PMID:24136188 | Rbm17 | Rat | folic acid | multiple interactions | ISO | Rbm17 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RBM17 mRNA | CTD | PMID:22206623 | Rbm17 | Rat | FR900359 | increases phosphorylation | ISO | RBM17 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of RBM17 protein | CTD | PMID:37730182 | Rbm17 | Rat | gemcitabine | decreases response to substance | ISO | RBM17 (Homo sapiens) | 6480464 | RBM17 protein results in decreased susceptibility to Gemcitabine | CTD | PMID:16061639 | Rbm17 | Rat | genistein | increases expression | ISO | RBM17 (Homo sapiens) | 6480464 | Genistein results in increased expression of RBM17 mRNA | CTD | PMID:26865667 | Rbm17 | Rat | indometacin | multiple interactions | ISO | RBM17 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Rbm17 | Rat | ivermectin | decreases expression | ISO | RBM17 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of RBM17 protein | CTD | PMID:32959892 | Rbm17 | Rat | lipopolysaccharide | multiple interactions | ISO | RBM17 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RBM17 mRNA | CTD | PMID:35811015 | Rbm17 | Rat | lipopolysaccharide | increases expression | ISO | RBM17 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of RBM17 mRNA | CTD | PMID:35811015 | Rbm17 | Rat | LY 117018 | multiple interactions | ISO | RBM17 (Homo sapiens) | 6480464 | LY 117018 inhibits the reaction [RBM17 protein results in decreased susceptibility to Mitoxantrone] | CTD | PMID:16061639 | Rbm17 | Rat | menadione | affects expression | ISO | RBM17 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of RBM17 mRNA | CTD | PMID:20044591 | Rbm17 | Rat | mitoxantrone | multiple interactions | ISO | RBM17 (Homo sapiens) | 6480464 | LY 117018 inhibits the reaction [RBM17 protein results in decreased susceptibility to Mitoxantrone]; Tamoxifen inhibits more ... | CTD | PMID:16061639 | Rbm17 | Rat | mitoxantrone | decreases response to substance | ISO | RBM17 (Homo sapiens) | 6480464 | RBM17 protein results in decreased susceptibility to Mitoxantrone | CTD | PMID:16061639 | Rbm17 | Rat | nickel sulfate | decreases expression | ISO | RBM17 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of RBM17 mRNA | CTD | PMID:16780908|PMID:17374397 | Rbm17 | Rat | nitrates | multiple interactions | ISO | Rbm17 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RBM17 more ... | CTD | PMID:35964746 | Rbm17 | Rat | Nivalenol | increases expression | ISO | RBM17 (Homo sapiens) | 6480464 | nivalenol results in increased expression of RBM17 protein | CTD | PMID:39638853 | Rbm17 | Rat | paracetamol | affects expression | ISO | Rbm17 (Mus musculus) | 6480464 | Acetaminophen affects the expression of RBM17 mRNA | CTD | PMID:17562736 | Rbm17 | Rat | pemetrexed | decreases response to substance | ISO | RBM17 (Homo sapiens) | 6480464 | RBM17 protein results in decreased susceptibility to Pemetrexed | CTD | PMID:16061639 | Rbm17 | Rat | phorone | affects expression | EXP | | 6480464 | phorone affects the expression of RBM17 mRNA | CTD | PMID:18198479 | Rbm17 | Rat | resveratrol | multiple interactions | ISO | RBM17 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of RBM17 mRNA | CTD | PMID:23557933 | Rbm17 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | RBM17 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RBM17 mRNA | CTD | PMID:35811015 | Rbm17 | Rat | sodium arsenite | decreases expression | ISO | RBM17 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of RBM17 mRNA | CTD | PMID:38568856 | Rbm17 | Rat | tamoxifen | multiple interactions | ISO | RBM17 (Homo sapiens) | 6480464 | Tamoxifen inhibits the reaction [RBM17 protein results in decreased susceptibility to Mitoxantrone] | CTD | PMID:16061639 | Rbm17 | Rat | temozolomide | decreases expression | ISO | RBM17 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of RBM17 mRNA | CTD | PMID:31758290 | Rbm17 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of RBM17 mRNA | CTD | PMID:31150632 | Rbm17 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RBM17 mRNA] | CTD | PMID:31150632 | Rbm17 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of RBM17 mRNA | CTD | PMID:34492290 | Rbm17 | Rat | valproic acid | increases expression | ISO | RBM17 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of RBM17 mRNA | CTD | PMID:23179753 | Rbm17 | Rat | valproic acid | decreases methylation | ISO | RBM17 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of RBM17 gene | CTD | PMID:29154799 | Rbm17 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of RBM17 mRNA | CTD | PMID:23555832 | Rbm17 | Rat | vincristine | decreases response to substance | ISO | RBM17 (Homo sapiens) | 6480464 | RBM17 protein results in decreased susceptibility to Vincristine | CTD | PMID:16061639 | Rbm17 | Rat | vinorelbine | decreases response to substance | ISO | RBM17 (Homo sapiens) | 6480464 | RBM17 protein results in decreased susceptibility to vinorelbine | CTD | PMID:16061639 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















